Baseline correction or supra-therapeutic dose [Regulatives / Guidelines]
Hi John,
first of all I agree with Lucas. I don’t get the idea of basing BE on uncorrected data. The EMA’s BE-GL is less ambiguous:
4.1.4 Study conduct
Standardisation
In bioequivalence studies of endogenous substances, factors that may influence the endogenous baseline levels should be controlled if possible (e.g. strict control of dietary intake).
Sampling times
For endogenous substances, the sampling schedule should allow characterisation of the endogenous baseline profile for each subject in each period. Often, a baseline is determined from 2–3 samples taken before the drug products are administered. In other cases, sampling at regular intervals throughout 1–2 day(s) prior to administration may be necessary in order to account for fluctuations in the endogenous baseline due to circadian rhythms (see section 4.1.5).
4.1.5 Characteristics to be investigated
Endogenous substances
If the substance being studied is endogenous, the calculation of pharmacokinetic parameters should be performed using baseline correction so that the calculated pharmacokinetic parameters refer to the additional concentrations provided by the treatment. Administration of supra-therapeutic doses can be considered in bioequivalence studies of endogenous drugs, provided that the dose is well tolerated, so that the additional concentrations over baseline provided by the treatment may be reliably determined.
If a separation in exposure following administration of different doses of a particular endogenous substance has not been previously established this should be demonstrated, either in a pilot study or as part of the pivotal bioequivalence study using different doses of the reference formulation, in order to ensure that the dose used for the bioequivalence comparison is sensitive to detect potential differences between formulations.
The exact method for baseline correction should be pre-specified and justified in the study protocol. In general, the standard subtractive baseline correction method, meaning either subtraction of the mean of individual endogenous pre-dose concentrations or subtraction of the individual endogenous predose AUC, is preferred. In rare cases where substantial increases over baseline endogenous levels are seen, baseline correction may not be needed.
In bioequivalence studies with endogenous substances, it cannot be directly assessed whether carryover has occurred, so extra care should be taken to ensure that the washout period is of an adequate duration.
first of all I agree with Lucas. I don’t get the idea of basing BE on uncorrected data. The EMA’s BE-GL is less ambiguous:
4.1.4 Study conduct
Standardisation
In bioequivalence studies of endogenous substances, factors that may influence the endogenous baseline levels should be controlled if possible (e.g. strict control of dietary intake).
Sampling times
For endogenous substances, the sampling schedule should allow characterisation of the endogenous baseline profile for each subject in each period. Often, a baseline is determined from 2–3 samples taken before the drug products are administered. In other cases, sampling at regular intervals throughout 1–2 day(s) prior to administration may be necessary in order to account for fluctuations in the endogenous baseline due to circadian rhythms (see section 4.1.5).
4.1.5 Characteristics to be investigated
Endogenous substances
If the substance being studied is endogenous, the calculation of pharmacokinetic parameters should be performed using baseline correction so that the calculated pharmacokinetic parameters refer to the additional concentrations provided by the treatment. Administration of supra-therapeutic doses can be considered in bioequivalence studies of endogenous drugs, provided that the dose is well tolerated, so that the additional concentrations over baseline provided by the treatment may be reliably determined.
If a separation in exposure following administration of different doses of a particular endogenous substance has not been previously established this should be demonstrated, either in a pilot study or as part of the pivotal bioequivalence study using different doses of the reference formulation, in order to ensure that the dose used for the bioequivalence comparison is sensitive to detect potential differences between formulations.
The exact method for baseline correction should be pre-specified and justified in the study protocol. In general, the standard subtractive baseline correction method, meaning either subtraction of the mean of individual endogenous pre-dose concentrations or subtraction of the individual endogenous predose AUC, is preferred. In rare cases where substantial increases over baseline endogenous levels are seen, baseline correction may not be needed.
In bioequivalence studies with endogenous substances, it cannot be directly assessed whether carryover has occurred, so extra care should be taken to ensure that the washout period is of an adequate duration.
—
Dif-tor heh smusma 🖖🏼 Довге життя Україна!
Helmut Schütz
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Dif-tor heh smusma 🖖🏼 Довге життя Україна!
Helmut Schütz
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Complete thread:
- Baseline correction vs non-baseline correction jag009 2015-09-15 20:29 [Regulatives / Guidelines]
- Baseline correction vs non-baseline correction Lucas 2015-09-16 14:16
- Baseline correction vs non-baseline correction Relaxation 2015-09-18 10:25
- Baseline correction or supra-therapeutic doseHelmut 2015-09-16 15:16
- Baseline correction or supra-therapeutic dose Ohlbe 2015-09-16 17:55
- Baseline profile prior to each period? Helmut 2015-09-16 18:15
- Baseline correction examples Helmut 2015-09-17 15:44
- Baseline correction examples Lucas 2015-09-18 14:19
- Baseline correction examples Helmut 2015-09-18 17:28
- Baseline correction examples Mauricio Sampaio 2016-02-07 03:05
- Baseline correction examples Lucas 2016-02-10 11:48
- Postmenopausal women Helmut 2016-02-10 12:26
- Baseline correction examples Mauricio Sampaio 2016-02-11 01:38
- Baseline correction examples Dr_Dan 2016-02-11 09:22
- Postmenopausal women Mauricio Sampaio 2016-02-12 03:24
- Postmenopausal women Dr_Dan 2016-02-15 17:45
- Postmenopausal women Mauricio Sampaio 2016-02-12 03:24
- Baseline correction examples Lucas 2016-02-10 11:48
- Baseline correction examples BEQool 2024-11-11 07:34
- Baseline correction GeoMean and Median mittyri 2024-11-11 11:20
- Geometric mean? Helmut 2024-11-11 14:53
- Geometric mean? BEQool 2024-11-14 08:19
- Geometric mean ≈ MLE of median Helmut 2024-11-14 09:54
- Geometric mean ≈ MLE of median Mahmoud 2024-11-15 11:26
- Geometric mean ≈ MLE of median Helmut 2024-11-14 09:54
- Geometric mean? BEQool 2024-11-14 08:19
- Geometric mean? Helmut 2024-11-11 14:53
- Baseline correction GeoMean and Median mittyri 2024-11-11 11:20
- Baseline correction examples Mauricio Sampaio 2016-02-07 03:05
- Baseline correction examples Helmut 2015-09-18 17:28
- Baseline correction examples Lucas 2015-09-18 14:19
- Baseline; another example Helmut 2015-09-18 17:16
- Baseline; another example nobody 2016-02-12 09:10
- Baseline; another example Helmut 2016-02-12 13:37
- Baseline; another example nobody 2016-02-12 14:08
- Slowly going OT: BE study simulations Helmut 2016-02-12 15:47
- Slowly going OT: BE study simulations nobody 2016-02-12 16:15
- Religious debate Helmut 2016-02-12 17:04
- Religious debate nobody 2016-02-12 17:26
- Religious debate ElMaestro 2016-02-13 12:53
- Religious debate nobody 2016-02-14 15:23
- Religious debate ElMaestro 2016-02-13 12:53
- Religious debate nobody 2016-02-12 17:26
- Religious debate Helmut 2016-02-12 17:04
- Slowly going OT: BE study simulations Ohlbe 2016-02-13 13:10
- Slowly going OT: BE study simulations Helmut 2016-02-13 15:02
- Slowly going OT: BE study simulations lizhao 2016-02-25 17:31
- Business as usual Helmut 2016-02-25 17:44
- Business as usual lizhao 2016-02-25 17:59
- Business as usual Helmut 2016-02-25 17:44
- Slowly going OT: BE study simulations lizhao 2016-02-25 17:31
- Slowly going OT: BE study simulations Helmut 2016-02-13 15:02
- Slowly going OT: BE study simulations nobody 2016-02-12 16:15
- Slowly going OT: BE study simulations Helmut 2016-02-12 15:47
- Baseline; another example nobody 2016-02-12 14:08
- Baseline; another example Helmut 2016-02-12 13:37
- Baseline; another example nobody 2016-02-12 09:10
- Baseline correction or supra-therapeutic dose Ohlbe 2015-09-16 17:55
- Baseline correction vs non-baseline correction Lucas 2015-09-16 14:16